J. Safra Sarasin Holding Ag Biogen Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.47 Trillion
- Q2 2024
A detailed history of J. Safra Sarasin Holding Ag transactions in Biogen Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 65,758 shares of BIIB stock, worth $13 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
65,758Holding current value
$13 Million% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,050Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.28 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$3.23 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.87 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.4 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1.12 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $28.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...